Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
New research suggests that people with peripheral artery disease (PAD) could have lower omega-3 levels in their red blood cells than people without the disease.
PAD affects 8.5 million Americans and more than 200 million people nationwide. It is a common circulatory problem that leads to narrowed arteries in the extremities and insufficient blood flow to keep up with demand. It damages the arteries in the same way that heart disease normally does. The process is called atherosclerosis.
Evidence from other studies shows that omega-3s improve cardiovascular health. They have been seen to improve the function of the lining of the blood vessels, delaying the development of atherosclerotic plaque, as well as exerting antioxidant, anti-inflammatory and antithrombotic actions.
In the study, the red blood cells fatty acid content of 145 patients with PAD and 34 people without the disease was analyzed. The ratio of omega-3 oils to omega-6 oils was also compared.
The results showed that PAD sufferers had lower average omega-3 levels and omega-3 to omega-6 ratio. In fact, just a 1% decrease in omega-3 levels was associated with a 39% increase in PAD risk. The total saturated fat level in the blood cells of PAD patients was also higher.
It is thought that these differences in fatty acid content could be linked to the development of the disease or poor health outcomes in those with PAD.
Related Biotics Research Products: 
Research information provided by OmegaQuant.
Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n-3 Polyunsaturated Fatty Acids Joel L. Ramirez, Greg J. Zahner, Kimberly A. Spaulding, Sukaynah A. Khetani, Nancy K. Hills, Warren J. Gasper, William S. Harris, Beth E. Cohen, S. Marlene Grenon. Lipids. 9 February 2019.
Submit this form and you'll receive our latest news and updates.
Results of a double-blind randomized and placebo-controlled trial evaluating the use of omega-3 fatty acid supplementati...
Learn moreA report on the intake of fish and omega-3 fatty acids among pregnant women in the U.S. was recently published in Public...
Learn moreA dose-response meta-analysis of randomized controlled trials on omega-3 polyunsaturated fatty acids (PUFAs) and blood p...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment